铁调素调节的生理与病理生理机制:铁代谢疾病的临床启示
本文综述了铁调素在系统性铁稳态中的核心作用及其调控机制,阐述了肝脏整合铁信号、红细胞生成驱动和炎症信号以控制铁调素产生,并讨论了铁调素失调如何导致铁缺乏或过载疾病,以及基于该知识的诊疗新策略。
要点
- 铁调素维持循环与储存铁平衡,限制铁毒性。
- 肝脏整合铁、红细胞生成和炎症信号调控铁调素。
- 铁调素失调导致铁缺乏或过载相关疾病。
核心结论
- 铁调素调控机制的理解为铁代谢疾病的诊断和治疗提供了新策略。
研究设计与样本
- 综述,讨论铁调素调节的分子机制及其在铁代谢疾病中的作用。
主要发现
- 铁调素保障循环与储存铁平衡,支持氧运输和红细胞生成,并限制铁毒性。
- 肝脏是整合铁、红细胞生成驱动和炎症信号以控制铁调素产生的主要部位。
- 遗传失活、无效红细胞生成或炎症导致的铁调素失调可引起铁缺乏或过载疾病。
临床怎么用
- 基于铁调素调控机制开发铁代谢疾病的新型诊断和治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The discovery of hepcidin has provided a solid foundation for understanding the mechanisms of systemic iron homeostasis and the aetiologies of iron disorders. Hepcidin assures the balance of circulating and stored iron levels for multiple physiological processes including oxygen transport and erythropoiesis, while limiting the toxicity of excess iron. The liver is the major site where regulatory signals from iron, erythropoietic drive and inflammation are integrated to control hepcidin production. Pathologically, hepcidin dysregulation by genetic inactivation, ineffective erythropoiesis, or inflammation leads to diseases of iron deficiency or overload such as iron-refractory iron-deficiency anaemia, anaemia of inflammation, iron-loading anaemias and hereditary haemochromatosis. In the present review, we discuss recent insights into the molecular mechanisms governing hepcidin regulation, how these pathways are disrupted in iron disorders, and how this knowledge is being used to develop novel diagnostic and therapeutic strategies.
引用
- Xu Y, Alfaro-Magallanes VM, Babitt JL, et al. Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders. Br J Haematol. 2020. PMID: 33316086. doi:10.1111/bjh.17252
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。